Metraipolis › archive › dc_6ae6bd3e73fa

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41732608
DOI
10.7759/cureus.102134
License (as archived)
solo-consultazione
Archived
2026-11-06T13:12:45.371Z
SHA-256 of the archived text
c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0
Stable URL of this page
https://metraipolis.com/documento/dc_6ae6bd3e73fa

How to cite

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608 — Europe PMC (en), https://europepmc.org/article/MED/41732608 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ae6bd3e73fa (Metraipolis archive dc_6ae6bd3e73fa, sha256 c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0)
BibTeX
@misc{dc6ae6bd3e73fa,
  title = {Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41732608},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ae6bd3e73fa; sha256 c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41732608. Agents can read the archived copy with the MCP tool read_document.